Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amer Jaber
COO | Chief Operating Officer | - | 18-12-31 |
Daniel Smith
CTO | Chief Tech/Sci/R&D Officer | - | 16-04-10 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
Nunzio Antonelli
BRD | Director/Board Member | - | 15-11-09 |
Valerie Benhamou
SEC | Corporate Secretary | - | 19-05-15 |
Jérôme Tilly
HRO | Human Resources Officer | - | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nunzio Antonelli
BRD | Director/Board Member | - | 15-11-09 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,728,000 | 0 | 0 | - |
Company contact information
Stallergenes Greer Ltd.
Tower Bridge House St Katharine's Way
E1W 1DD, London
+
http://www.stallergenesgreer.comGroup companies
Name | Category and Sector |
---|---|
Stallergenes SAS
|
Sector
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- STAGR Stock
- Company Stallergenes Greer